Endometrioma Cerrahisinin Serum AMH Düzeyleri Üzerine Olan Etkisi

Ozet Endometriomalarin cerrahi tedavisi normal ovarian korteksin harap olmasi ya da yetersiz cerrahi gibi bircok riskler tasir. Anti mullerian hormon tumor buyume faktoru beta ailesinin bir uyesidir ve 8 mm’den daha kucuk olan preantral ve erken antral follikullerden salinir. AMH primordial follikul havuzunun bir gostergesi gibi gorev yapar. AMH en iyi ovarian rezerv belirtecidir. Bu nedenle, biz AMH’nin endometrioma cerrahisi sonrasi ovarian rezerv uzerindeki etkileri degerlendirmede yararli olabilecegini dusunduk. Abstract Surgical treatment of endometriomas possess many risks such as destruction of normal ovarian cortex and inadequate surgery. Anti mullerian hormone (AMH) is a member of the tumor growth factor  (TGF) beta family and released from the small (<8 mm) preantral and early antral follicles. It serves as an indicator for the primordial follicle pool. AMH is the best ovarian reserve marker. Therefore, we thought that AMH could be useful to evaluate the effect of endometrioma surgery on ovarian reserve.